ARGX
NASD argenx SE Sponsored ADR$972.25 ↑ +0.00 (+0.00%) Trading Up from the previous close of $972.25, $4.76 below the day’s high of $977.01
- YTD change
- +15.61%
- vs 20-day SMA
- -2.60%
- vs 200-day SMA
- +14.46%
Price ranges
Price & Performance
+267.94 (+38.04%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 9.4% away from all-time highs of $1,072.75
- ARGX is up 16% since the beginning of the year
- ARGX is up 37% over the past 12 months
- ARGX is down 8% over the past 1 month
- 2% of all ARGX investors are betting against ARGX
ARGX reads very good: price sits above one of the two key moving averages, the 12-month move is +35.2%.
- Previous minute
- +$0.00
- Last hour
- +$2.25
- Last 5 days
- -1.82%
- vs 8-day SMA
- -0.16%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
